about
Fluoxetine exerts age-dependent effects on behavior and amygdala neuroplasticity in the rat.Repeated ketamine exposure induces an enduring resilient phenotype in adolescent and adult rats.The Subjective Experience of Youth Psychotropic Treatment.Short- and long-term functional consequences of fluoxetine exposure during adolescence in male rats.Off-label prescribing patterns of antidepressants in children and adolescents.Do Hospital and Community SSRI Usage Patterns in Children and Adolescents Match the Evidence?Children's mental health services in fee-for-service Medicaid.The Food and Drug Administration's deliberations on antidepressant use in pediatric patients.The effects of Psychotropic drugs On Developing brain (ePOD) study: methods and designA drug utilisation study of antidepressants in children and adolescents using the General Practice Research DatabaseAntidepressant use in children and adolescents: Practice touch points to guide paediatricians.Antidepressants and youth: healing or harmful?Mother's country of birth and prescription of psychotropic medication in Swedish adolescents: a life course approachWhat should non-US behavioral health systems learn from the USA?: US behavior health services trends in the 1980s and 1990s.Executive Attention Impairment in Adolescents With Major Depressive Disorder.Medication prescribing practices in a child and adolescent psychiatry outpatient clinic.Psychotropic medication treatment of adolescents: results from the National Comorbidity Survey-Adolescent Supplement.Outside the Black Box: Re-assessing Pediatric Antidepressant PrescriptionThe contribution of pharmacoepidemiology to the antidepressant-suicidality debate in children and adolescents.Changing utilization of pro re nata ('as needed') sedation in a child and adolescent psychiatric inpatient unit.An update on antidepressant use and suicidality in pediatric depression.Polypharmacy with antidepressants in children and adolescents.Psychiatric neural networks and neuropharmacology: Selected advances and novel implicationsPrescribing practices of psychiatrists and primary care physicians caring for children with mental illness.Interprovincial Variation in Antipsychotic and Antidepressant Prescriptions Dispensed in the Canadian Pediatric Population.Facing the evidence: antidepressant treatment in children and adolescents.Increase in non-evidence based use of antidepressants in children is cause for concern.Twenty-year trends in emotional and behavioral problems in Dutch children in a changing society.Antidepressants, suicide, and the FDA: a loose association.Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.Trends, correlates, and disease patterns of antidepressant use among children and adolescents in Taiwan.Trends in psychostimulant and antidepressant use by children in 2 Canadian provinces.Explaining racial and ethnic differences in antidepressant use among adolescents.Antidepressants in child and adolescent depression: where are the bugs?
P2860
Q30477109-C497BD62-A312-4F01-A253-913ABBCACBBAQ30547324-5B8D7E9C-027F-41A3-A15D-006E52D97173Q33755004-EC087C14-AC67-4F4C-8AF9-184F7CE95AC5Q33843546-F3C3891F-8121-446B-B2FF-2DB079EDDEE7Q33888378-12FBD325-E7A8-4B90-ADAD-2654F9892ACDQ34124607-5C1C15A5-299A-4233-BD62-066D3C1B95E4Q34328174-4726ADB6-6C14-4255-A19E-8D2EC6975EDBQ34998784-A96FA72E-CDE6-49F8-A8DE-9F0D3535CD5DQ35098070-E52238D5-1B9F-436E-8D66-1B1EA75C44DAQ35277907-A22714E2-FF20-4936-ABB9-B9F8C4FFDDF2Q35572613-DC826D66-E8C1-49E3-9B4E-C8C3E06748E8Q36029861-2A0200F8-6D44-4837-9307-3B0C072D29D7Q36306919-56643245-F51E-4C9D-B23D-6CEC6691535EQ36491865-7E272A30-92B6-4F38-8F4B-F3D29F0A4296Q36515288-53B72AA5-C443-4733-8F8B-E7DAB9394A35Q36855978-64005BBD-57C4-46F4-9F91-6E3ABDFF9733Q36877283-305015AB-8020-4561-ACCF-C8C11D4E77E8Q37112065-4AA68612-DDE7-472C-B0B8-D55C4B9FAB46Q37127465-BAE1F525-D5B4-4C0E-8CC0-66CDB7435479Q37417592-4827E986-5ED5-41B2-9DB9-58C93CB512F1Q38044018-4E481D9D-34A3-4E60-A534-79BC6D91B810Q38063355-5D4C0641-6D98-44A5-9811-208F14877654Q38197608-04088F26-55DE-470D-AAEB-D39B6DE0C0C2Q38469855-FB75CC5A-C6C4-4737-9A3D-8A89DF7FFB2AQ38852277-C6FBEFC7-BE40-4B0D-A080-2E903188EF76Q40526661-B2BE8120-3B9A-4C04-946C-3FA57258660BQ43204468-F7F9D601-92BE-4A4F-979F-026E61728CCAQ43523282-69D1B067-40D5-4606-8A14-BE7406A8A412Q45038806-B48AE825-53DF-4484-9F8E-67C28EDB2A8DQ46879239-BDD28BB4-9566-48E1-9BBA-5F185C6C73B0Q48638481-5C0BE60C-BAB0-4348-8C3B-10848BD6C8F9Q51116234-34609386-8833-419D-91C4-D6E1777F5529Q51860609-1456AAF1-6192-4912-A836-B06A9B576872Q51994285-2FE461BC-4492-4564-836C-2E54BB51AAD1
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Rising prevalence of antidepressants among US youths.
@ast
Rising prevalence of antidepressants among US youths.
@en
Rising prevalence of antidepressants among US youths.
@nl
type
label
Rising prevalence of antidepressants among US youths.
@ast
Rising prevalence of antidepressants among US youths.
@en
Rising prevalence of antidepressants among US youths.
@nl
prefLabel
Rising prevalence of antidepressants among US youths.
@ast
Rising prevalence of antidepressants among US youths.
@en
Rising prevalence of antidepressants among US youths.
@nl
P2093
P356
P1433
P1476
Rising prevalence of antidepressants among US youths.
@en
P2093
Daniel J Safer
Frances Lynch
James F Gardner
Julie Magno Zito
Karen Soeken
Myde Boles
Susan DosReis
P304
P356
10.1542/PEDS.109.5.721
P407
P577
2002-05-01T00:00:00Z